Literature DB >> 34935612

In Reply.

Knut Mai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34935612      PMCID： PMC8727859          DOI： 10.3238/arztebl.m2021.0314

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  5 in total

Review 1.  The rational use of pituitary stimulation tests.

Authors:  Stephan Petersenn; Hans-Jürgen Quabbe; Christof Schöfl; Günter K Stalla; Klaus von Werder; Michael Buchfelder
Journal:  Dtsch Arztebl Int       Date:  2010-06-25       Impact factor: 5.594

2.  ICPis-Induced Autoimmune Polyendocrine Syndrome Type 2: A Review of the Literature and a Protocol for Optimal Management.

Authors:  Yun Shi; Min Shen; Xuqin Zheng; Yang Chen; RuiLing Zhao; Yong Gu; Tao Yang
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

3.  Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.

Authors:  M Maghnie; E Uga; F Temporini; N Di Iorgi; A Secco; C Tinelli; A Papalia; M R Casini; S Loche
Journal:  Eur J Endocrinol       Date:  2005-05       Impact factor: 6.664

4.  The Diagnosis and Management of Endocrine Side Effects of Immune Checkpoint Inhibitors.

Authors:  Knut Mai; Martin Fassnacht; Dagmar Führer-Sakel; Jürgen B Honegger; Matthias M Weber; Matthias Kroiss
Journal:  Dtsch Arztebl Int       Date:  2021-06-11       Impact factor: 5.594

5.  Immune-checkpoint inhibitor-associated diabetes compared to other diabetes types - A prospective, matched control study.

Authors:  Sascha R Tittel; Katharina Laubner; Sebastian M Schmid; Stefan Kress; Sigrun Merger; Wolfram Karges; Frank J Wosch; Marcus Altmeier; Marianne Pavel; Reinhard W Holl
Journal:  J Diabetes       Date:  2021-07-29       Impact factor: 4.006
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.